McKesson Corp. Stock
McKesson Corp. Stock
There is an upward development for McKesson Corp. compared to yesterday, with an increase of €8.60 (1.250%).
With 31 Buy predictions and not a single Sell prediction McKesson Corp. is an absolute favorite of our community.
With a target price of 716 € there is a slightly positive potential of 3.59% for McKesson Corp. compared to the current price of 691.2 €.
Pros and Cons of McKesson Corp. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of McKesson Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| McKesson Corp. | 1.250% | -0.489% | -6.997% | 25.490% | 25.673% | 96.587% | 387.860% |
| Cardinal Health Inc. | 0.560% | 0.533% | -5.007% | 51.946% | 50.133% | 127.066% | 278.174% |
| CVS Health Corp. | 0.210% | -3.588% | -1.367% | 51.986% | 56.133% | -26.334% | 16.907% |
| AmerisourceBergen Corp. | -0.720% | -0.988% | -6.980% | 32.618% | 34.149% | 84.632% | 258.642% |
Comments
McKesson (NYSE:MCK) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Show more
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its price target raised by analysts at UBS Group AG from $920.00 to $980.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat